HEART RETRANSPLANTATION-Reference-Cited by-同舟云学术

HEART RETRANSPLANTATION

Published:2016-06-25 Issue:2 Volume:18 Page:142-151
ISSN:2412-6160
Container-title:Russian Journal of Transplantology and Artificial Organs
language:
Short-container-title:RJTAO

Author:

Saitgareev R. Sh.¹,Zakharevich V. M.²,Golts A. M.¹,Khalilulin T. A.²,Borisov D. V.¹

Affiliation:

1. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow

2. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow; I.M. Sechenov First Moscow State Medical University, Moscow

Abstract

The number of patients with transplanted heart is continuously increasing; therefore, the number of patients requiring heart retransplantation grows. Analysis of the results of published studies focused on safety of cardiac retransplantation and risk factors for adverse events in perioperative, early and late postoperative periods is presented in our review. The results of published studies suggest that heart retransplantation is the main radical treatment option for cardiac allograft dysfunction, but the results of heart retransplantation are slightly worse than those of primary cardiac transplantation. On the other hand, the favorable long-term prognosis after heart retransplantation should be expected in carefully selected recipients.

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference54 articles.

1. Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015 Oct; 34 (10): 1244–1254. doi: 10.1016/j.healun.2015.08. 003. Epub 2015 Aug 28.

2. Atluri P, Hiesinger W, Gorman RC, Pochettino A, Jessup M, Acker MA et al. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. J Cardiothorac Surg. 2008 May 7; 3: 26. doi: 10.1186/1749-8090-3-26.

3. Clerkin KJ, Thomas SS, Haythe J, Schulze PC, Farr M, Takayama H et al. Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience. J Heart Lung Transplant. 2015 Feb; 34 (2): 161–166. doi: 10.1016/j.healun.2014.09.033. Epub 2014 Sep 28.

4. Kalya A, Jaroszewski D, Pajaro O, Scott R, Gopalan R, Kasper D, Arabia F. Role of total artificial heart in the management of heart transplant rejection and retransplantation: case report and review. Clin Transplant. 2013 Jul-Aug; 27 (4): E348–50. doi: 10.1111/ctr.12146. Epub 2013 May 31.

5. Ricci M, Panos AL, Andreopoulos FM, Rusconi P, Rosenkranz E, Barron M, Pham SM. Successful use of a custom-made paracorporeal total artificial heart as a bridge to retransplantation in adult and adolescent patients. J Heart Lung Transplant. 2009 Aug; 28 (8): 834–837. doi: 10.1016/j.healun.2009.05.008.